Health ProductsType I recall EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination.
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: EPINEPHRINE INJECTION USP, SODIUM BICARBONATE INJECTION USP & DEXTROSE INJECTION USP
Issue: Health products - Contamination
What to do: Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution: National
Audience: General public, Healthcare, Industry
Recall class: Type I
We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.
Get health product recall alertsCA$3.99/mo · cancel anytime
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|
| Pfizer | EPINEPHRINE INJECTION USP | DIN 00710814 | Intravenous Solution | EPINEPHRINE 1mg / mL | LR4585, LN2814, LN2813 & LX1239 |
| Pfizer | SODIUM BICARBONATE INJECTION USP | DIN 00261998 | Intravenous Solution | SODIUM BICARBONATE 84 mg / mL | LN0968, LP9658, LW7842, LR4597, LN0970, MA4046, MA4048, LY3748, MA8144 & MD0507 |
| Pfizer | DEXTROSE INJECTION USP | DIN 02468514 | Intravenous Solution | Dextrose 500 mg / mL | LH2756 & LY3589 |
Affected lots may contain the presence of microbiological contamination.